Phase I combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 33; no. 15_suppl; p. 2588
Main Authors Rodrigues, Heloisa Veasey, Lim, JoAnn, Stephen, Bettzy, Janku, Filip, Tsimberidou, Apostolia Maria, Piha-Paul, Sarina Anne, Fu, Siqing, Naing, Aung, Subbiah, Vivek, Falchook, Gerald Steven, Kurzrock, Razelle, Wheler, Jennifer J.
Format Journal Article
LanguageEnglish
Published 20.05.2015
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2015.33.15_suppl.2588